
Canopy Growth (NASDAQ: CGC)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Canopy Growth Returns vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Canopy Growth Company Info
Canopy Growth Corp. is currently the worlds largest medical cannabis company. The company operates 10 licensed cannabis production sites, operates four Tweed Main Street locations in Ontario, and has operations in 11 countries across five continents.
News & Analysis
Cannabis companies may be better off avoiding Canada.
The marijuana company has been tripped up by the troubled legalization effort in Canada.
They're not ripe to buy right now, but it's worth seeing if that changes.
The returns in the cannabis industry haven't come close to living up to the hype.
It doesn't appear that the Canadian market is a priority for the business anymore.
Canopy Growth dropped another bombshell on investors today.
Do the rewards outweigh the risks in cannabis stocks right now?
Valuation
Podcast Episodes

One of the marijuana industry’s pioneers was just ousted from Canopy Growth. What comes next?

Bruce Linton talks with us about running the biggest pure-play marijuana company, and the future of the marijuana industry.
Earnings Transcripts
CGC earnings call for the period ending December 31, 2022.
CGC earnings call for the period ending September 30, 2022.
CGC earnings call for the period ending March 31, 2022.
CGC earnings call for the period ending December 31, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.